Send me a link:

*Only U.S. numbers are accepted. Text messaging rates may apply.

 Dow Down0.10% Nasdaq Up0.23%

More On PBMD

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials


Prima Biomed Ltd. (PBMD)

-NasdaqGM
1.04 Down 0.04(3.70%) Apr 17, 4:00PM EDT
Get the big picture on all your investments.
ProfileGet Profile for:
Prima Biomed Ltd.
151 Macquarie Street
Level 7
Sydney, NSW 2000
Australia - Map
Phone: 61 2 9276 1224
Fax: 61 2 9276 1284
Website: http://www.primabiomed.com.au

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Biotechnology
Full Time Employees:30

Business Summary 

Prima BioMed Ltd., a biotechnology company, researches, develops, and commercializes licensed medical biotechnology products in Australia. Its lead product includes CVac, a cancer vaccine for patients in remission, which has completed two human clinical trials. The company is also developing oral vaccine against human papilloma virus, a virus associated with development of cervical cancer. Prima BioMed Ltd. is based in Sydney, Australia.

Key Statistics


Company Websites 
Home Page
Search Yahoo! for:
More on Prima Biomed Ltd.

Key Executives 
 PayExercised
Mr. Matthew Lehman , 37
Chief Exec. Officer and Exec. Director
336.00KN/A
Mr. Marc Voigt , 41
Chief Financial Officer and Chief Bus. Officer
222.00KN/A
Dr. Sharron Gargosky Ph.D., 50
Chief Technical Officer
298.00KN/A
Ms. Deanne Miller LLB, 37
Gen. Counsel and Company Sec.
116.00KN/A
Ms. Marta Schilling ,
VP of Manufacturing
N/AN/A
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.